| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8786688 | European Journal of Surgical Oncology (EJSO) | 2018 | 23 Pages |
Abstract
Our study demonstrated that RFX1 downregulation is a new predictive marker of high recurrence risk and poor prognosis of HCC; It has potential to help guide treatment for postoperative HCC patients, especially for small HCC patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Yingjun Liu, Peng Jiang, Gangcheng Wang, Xiaonyong Liu, Suxia Luo,